These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
724 related articles for article (PubMed ID: 28012977)
1. Two-stage implant-based breast reconstruction compared with immediate one-stage implant-based breast reconstruction augmented with an acellular dermal matrix: an open-label, phase 4, multicentre, randomised, controlled trial. Dikmans RE; Negenborn VL; Bouman MB; Winters HA; Twisk JW; Ruhé PQ; Mureau MA; Smit JM; Tuinder S; Eltahir Y; Posch NA; van Steveninck-Barends JM; Meesters-Caberg MA; van der Hulst RR; Ritt MJ; Mullender MG Lancet Oncol; 2017 Feb; 18(2):251-258. PubMed ID: 28012977 [TBL] [Abstract][Full Text] [Related]
2. Quality of life and patient satisfaction after one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction (BRIOS): primary outcome of a randomised, controlled trial. Negenborn VL; Young-Afat DA; Dikmans REG; Smit JM; Winters HAH; Don Griot JPW; Twisk JWR; Ruhé PQ; Mureau MAM; Lapid O; Moerman E; van Turnhout AAWM; Ritt MJPF; Bouman MB; Mullender MG Lancet Oncol; 2018 Sep; 19(9):1205-1214. PubMed ID: 30104147 [TBL] [Abstract][Full Text] [Related]
3. Implant Based Breast Reconstruction With Acellular Dermal Matrix: Safety Data From an Open-label, Multicenter, Randomized, Controlled Trial in the Setting of Breast Cancer Treatment. Lohmander F; Lagergren J; Roy PG; Johansson H; Brandberg Y; Eriksen C; Frisell J Ann Surg; 2019 May; 269(5):836-841. PubMed ID: 30308615 [TBL] [Abstract][Full Text] [Related]
4. Short-term cost-effectiveness of one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage expander-implant reconstruction from a multicentre randomized clinical trial. Negenborn VL; Smit JM; Dikmans REG; Winters HAH; Twisk JWR; Ruhé PQ; Mureau MAM; Tuinder S; Eltahir Y; Posch NAS; van Steveninck-Barends JM; van der Hulst RRWJ; Ritt MJPF; Bouman MB; Mullender MG Br J Surg; 2019 Apr; 106(5):586-595. PubMed ID: 30835827 [TBL] [Abstract][Full Text] [Related]
5. Effect of Immediate Implant-Based Breast Reconstruction After Mastectomy With and Without Acellular Dermal Matrix Among Women With Breast Cancer: A Randomized Clinical Trial. Lohmander F; Lagergren J; Johansson H; Roy PG; Brandberg Y; Frisell J JAMA Netw Open; 2021 Oct; 4(10):e2127806. PubMed ID: 34596671 [TBL] [Abstract][Full Text] [Related]
6. Acellular dermal matrices as an adjunct to implant breast reconstruction: Analysis of outcomes and complications. Tasoulis MK; Teoh V; Khan A; Montgomery C; Mohammed K; Gui G Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):511-515. PubMed ID: 31706716 [TBL] [Abstract][Full Text] [Related]
7. A direct comparison of porcine (Strattice™) and bovine (Surgimend™) acellular dermal matrices in implant-based immediate breast reconstruction. Ball JF; Sheena Y; Tarek Saleh DM; Forouhi P; Benyon SL; Irwin MS; Malata CM J Plast Reconstr Aesthet Surg; 2017 Aug; 70(8):1076-1082. PubMed ID: 28624524 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcome and patient satisfaction with the use of bovine-derived acellular dermal matrix (SurgiMend™) in implant based immediate reconstruction following skin sparing mastectomy: A prospective observational study in a single centre. Headon H; Kasem A; Manson A; Choy C; Carmichael AR; Mokbel K Surg Oncol; 2016 Jun; 25(2):104-10. PubMed ID: 27312036 [TBL] [Abstract][Full Text] [Related]
9. Quality of life and patient satisfaction after implant-based breast reconstruction with or without acellular dermal matrix: randomized clinical trial. Lohmander F; Lagergren J; Johansson H; Roy PG; Frisell J; Brandberg Y BJS Open; 2020 Oct; 4(5):811-820. PubMed ID: 32762012 [TBL] [Abstract][Full Text] [Related]
10. Outcome of the use of acellular-dermal matrix to assist implant-based breast reconstruction in a single centre. Barber MD; Williams L; Anderson ED; Neades GT; Raine C; Young O; Kulkarni D; Young I; Dixon JM Eur J Surg Oncol; 2015 Jan; 41(1):100-5. PubMed ID: 25238954 [TBL] [Abstract][Full Text] [Related]
11. Does the use of acellular dermal matrices (ADM) in women undergoing pre-pectoral implant-based breast reconstruction increase operative success versus non-use of ADM in the same setting? A systematic review protocol. Cook H; Zargaran D; Glynou SP; Hamilton S; Mosahebi A Syst Rev; 2024 Jun; 13(1):153. PubMed ID: 38849880 [TBL] [Abstract][Full Text] [Related]
12. The Multi Centre Canadian Acellular Dermal Matrix Trial (MCCAT): study protocol for a randomized controlled trial in implant-based breast reconstruction. Zhong T; Temple-Oberle C; Hofer SO; Beber B; Semple J; Brown M; Macadam S; Lennox P; Panzarella T; McCarthy C; Baxter N; Trials; 2013 Oct; 14():356. PubMed ID: 24165392 [TBL] [Abstract][Full Text] [Related]
13. Does the use of Acellular Dermal Matrices (ADM) in women undergoing pre-pectoral implant-based breast reconstruction increase operative success versus non-use of ADM in the same setting? A systematic review. Cook HI; Glynou SP; Sousi S; Zargaran D; Hamilton S; Mosahebi A BMC Cancer; 2024 Sep; 24(1):1186. PubMed ID: 39333948 [TBL] [Abstract][Full Text] [Related]
14. [Mastectomy and immediate breast reconstruction using a prosthesis and lower dermal flap: description of five cases]. Clerico C; Ihrai T; Raoust I; Chignon-Sicard B; Georgiou C; Flipo B Ann Chir Plast Esthet; 2012 Dec; 57(6):606-11. PubMed ID: 22868066 [TBL] [Abstract][Full Text] [Related]
15. Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction - A prospective randomized trial. Gschwantler-Kaulich D; Schrenk P; Bjelic-Radisic V; Unterrieder K; Leser C; Fink-Retter A; Salama M; Singer C Eur J Surg Oncol; 2016 May; 42(5):665-71. PubMed ID: 26947961 [TBL] [Abstract][Full Text] [Related]
16. Direct-to-implant breast reconstruction: Higher complication rate vs cosmetic benefits. Gschwantler-Kaulich D; Leser C; Salama M; Singer CF Breast J; 2018 Nov; 24(6):957-964. PubMed ID: 30230119 [TBL] [Abstract][Full Text] [Related]
17. Predictors of complications after direct-to-implant breast reconstruction with an acellular dermal matrix from a multicentre randomized clinical trial. Negenborn VL; Dikmans REG; Bouman MB; Winters HAH; Twisk JWR; Ruhé PQ; Mureau MAM; Smit JM; Tuinder S; Hommes J; Eltahir Y; Posch NAS; van Steveninck-Barends JM; Meesters-Caberg MA; van der Hulst RRWJ; Ritt MJPF; Mullender MG Br J Surg; 2018 Sep; 105(10):1305-1312. PubMed ID: 29663320 [TBL] [Abstract][Full Text] [Related]
18. BROWSE: A multicentre comparison of nine year outcomes in acellular dermal matrix based and complete submuscular implant-based immediate breast reconstruction-aesthetics, capsular contracture and patient reported outcomes. Wilson RL; Kirwan CC; O'Donoghue JM; Linforth RA; Johnson RK; Harvey JR Eur J Surg Oncol; 2022 Jan; 48(1):73-81. PubMed ID: 34836730 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Reconstructive Outcomes in Breast Cancer Patients With Preexisting Subpectoral Implants: Implant-Sparing Mastectomy With Delayed Implant Exchange Versus Immediate Tissue Expander Reconstruction. Parabkaharan S; Melody M; Trotta R; Lleshi A; Sun W; Smith PD; Khakpour N; Dayicioglu D Ann Plast Surg; 2016 Jun; 76 Suppl 4():S332-5. PubMed ID: 27187252 [TBL] [Abstract][Full Text] [Related]
20. Review: Implant-Based Breast Reconstruction After Mastectomy for Breast Cancer: A Meta-analysis of Randomized Controlled Trials and Prospective Studies Comparing Use of Acellular Dermal Matrix (ADM) Versus Without ADM. Ng TP; Loo BYK; Yong N; Chia CLK; Lohsiriwat V Ann Surg Oncol; 2024 May; 31(5):3366-3376. PubMed ID: 38285304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]